» Articles » PMID: 36744297

The Mechanosensitive TRPV2 Calcium Channel Promotes Human Melanoma Invasiveness and Metastatic Potential

Abstract

Melanoma is a highly aggressive cancer endowed with a unique capacity of rapidly metastasizing, which is fundamentally driven by aberrant cell motility behaviors. Discovering "migrastatics" targets, specifically controlling invasion and dissemination of melanoma cells during metastasis, is therefore of primary importance. Here, we uncover the prominent expression of the plasma membrane TRPV2 calcium channel as a distinctive feature of melanoma tumors, directly related to melanoma metastatic dissemination. In vitro as well as in vivo, TRPV2 activity is sufficient to confer both migratory and invasive potentials, while conversely TRPV2 silencing in highly metastatic melanoma cells prevents aggressive behavior. In invasive melanoma cells, TRPV2 channel localizes at the leading edge, in dynamic nascent adhesions, and regulates calcium-mediated activation of calpain and the ensuing cleavage of the adhesive protein talin, along with F-actin organization. In human melanoma tissues, TRPV2 overexpression correlates with advanced malignancy and poor prognosis, evoking a biomarker potential. Hence, by regulating adhesion and motility, the mechanosensitive TRPV2 channel controls melanoma cell invasiveness, highlighting a new therapeutic option for migrastatics in the treatment of metastatic melanoma.

Citing Articles

Structural insights into TRPV2 modulation by probenecid.

Rocereta J, Sturhahn T, Pumroy R, Fricke T, Herzog C, Leffler A Nat Struct Mol Biol. 2025; .

PMID: 39972168 DOI: 10.1038/s41594-025-01494-9.


TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy.

Li Q, Li H, Zhu R, Cho W, Yao X, Leung F Cancer Cell Int. 2024; 24(1):324.

PMID: 39334351 PMC: 11438410. DOI: 10.1186/s12935-024-03506-y.


The biophysics of cell motility through mechanochemically challenging environments.

Caruso A, Logue J Curr Opin Cell Biol. 2024; 90:102404.

PMID: 39053178 PMC: 11392632. DOI: 10.1016/j.ceb.2024.102404.


Functional and structural insights into activation of TRPV2 by weak acids.

Haug F, Pumroy R, Sridhar A, Pantke S, Dimek F, Fricke T EMBO J. 2024; 43(11):2264-2290.

PMID: 38671253 PMC: 11148119. DOI: 10.1038/s44318-024-00106-4.


Piezo1 Activation Prevents Spheroid Formation by Malignant Melanoma SK-MEL-2 Cells.

Vasileva V, Khairullina Z, Chubinskiy-Nadezhdin V Int J Mol Sci. 2023; 24(21).

PMID: 37958687 PMC: 10648948. DOI: 10.3390/ijms242115703.


References
1.
Siveen K, Nizamuddin P, Uddin S, Al-Thani M, Frenneaux M, Janahi I . TRPV2: A Cancer Biomarker and Potential Therapeutic Target. Dis Markers. 2020; 2020:8892312. PMC: 7746447. DOI: 10.1155/2020/8892312. View

2.
Monet M, Gkika D, Lehenkyi V, Pourtier A, Vanden Abeele F, Bidaux G . Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta. 2009; 1793(3):528-39. DOI: 10.1016/j.bbamcr.2009.01.003. View

3.
Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H . Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol. 2009; 297(3):C493-502. DOI: 10.1152/ajpcell.00624.2008. View

4.
Pedri D, Karras P, Landeloos E, Marine J, Rambow F . Epithelial-to-mesenchymal-like transition events in melanoma. FEBS J. 2021; 289(5):1352-1368. DOI: 10.1111/febs.16021. View

5.
Ju R, Stehbens S, Haass N . The Role of Melanoma Cell-Stroma Interaction in Cell Motility, Invasion, and Metastasis. Front Med (Lausanne). 2018; 5:307. PMC: 6232165. DOI: 10.3389/fmed.2018.00307. View